K232216Substantially Equivalent
Hemoblock_S (Prescription); Hemoblock_S (OTC)
Incore Co., Ltd., Daegu, KR / Traditional, Substantially Equivalent
K232216 is the FDA 510(k) clearance record for Hemoblock_S (Prescription); Hemoblock_S (OTC), cleared for Incore Co., Ltd. on under FDA product code QSY (Hemostatic Wound Dressing Without Thrombin Or Other Biologics). FDA's definition for product code QSY reads: "To temporarily control bleeding and cover external wounds". FDA records list 6 510(k) clearances for Incore Co., Ltd., from to . As of , FDA records show no recalls naming K232216.
Clearance record
- Decision date
- Received
- (268 days to decision)
- Product code
- QSY Hemostatic Wound Dressing Without Thrombin Or Other Biologics
- Device class
- Unclassified
- Review panel
- Unknown
- Applicant
- Incore Co., Ltd. 11, Hyeoksin-Daero 78-Gil, Dong-Gu, Daegu, KR
- 510(k) summary
- Summary PDF
- Third party review
- No
Clearances, product code QSY
Trailing 12 monthsShow the numbers
| Month | Clearances |
|---|---|
| November 2025 | 0 |
| December 2025 | 2 |
| January 2026 | 0 |
| February 2026 | 1 |
| March 2026 | 0 |
| April 2026 | 1 |
| May 2026 | 0 |
| June 2026 | 0 |
| July 2026 | 0 |
| August 2026 | 0 |
| September 2026 | 0 |
| October 2026 | 0 |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
